Virax Biolabs collaborates with the University of Manchester to enhance T-cell diagnostics for long COVID, aiming to improve early detection and treatment of post-viral syndromes. Listen to this interview to learn more.
Virax Biolabs, a biotechnology company specializing in diagnostic technology, is developing an advanced T-cell immunology platform to enable early diagnosis of post-viral syndromes like long COVID and conditions related to chronic inflammation and T-cell exhaustion.
In a recent interview, Virax Bio Labs Virax chief operating officer Nigel McCracken, PhD, MS, spoke with Infection Control Today® (ICT®) about their T-Cell immunology technology. He discussed Virax’s pioneering work on a T-cell immunology platform designed to improve diagnostics for post-viral syndromes like long COVID. Current tests primarily detect acute infections, but there’s no standardized diagnostic tool to address the complex, chronic nature of long COVID. Virax Biolabs aims to fill this gap by focusing on immune system dysfunction, specifically T-cell activity, which is crucial in managing post-viral syndromes.
The company partnered with the University of Manchester to conduct a study to gain deeper insights into immune responses in COVID-19 patients. This research will specifically focus on individuals experiencing symptoms of long COVID. Utilizing the Virax T-cell assay, the study will longitudinally assess samples from a selected cohort to identify unique phenotypic T-cell profiles associated with these patients.
This collaboration represents a significant step toward understanding immune dysfunction in long COVID, potentially paving the way for more targeted diagnostic and therapeutic approaches for patients suffering from post-viral syndromes.
“Remember when we talk about long COVID, or we talk about post-viral syndromes, we're talking about symptoms that are so different,” McCracken said. “If you read a lot—and certainly in the US press and also in the UK press—[you see] people have been living with [Myalgic encephalomyelitis (ME)] or chronic fatigue syndrome for 40 [or] 50 years. I've got many, many people I know, as well as relatives [who] have had this [issue.]”
McCracken continued, “[The] interesting thing is, when you look at the symptoms, they're not all the same, but there's an awful lot of commonality around symptoms of long COVID and symptoms of ME, or even Lyme disease if Lyme disease is left for a long period, for things like chronic fatigue, a lot of the cognitive stuff, [and] the post-exercise fatigue and stuff.”
This groundbreaking work offers hope for patients struggling with post-viral conditions and highlights the importance of early detection and targeted therapies in managing chronic inflammation and immune dysfunction.
Listen to this fascinating and enlightening interview to learn more.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.